Ola Bratt

affiliated with the university
More filtering options
  1. 2019
  2. A randomised trial comparing two protocols for transrectal prostate repeat biopsy: six lateral posterior plus six anterior cores versus a standard posterior 12-core biopsy

    Örtegren, J., Holmberg, J. T., Lekås, E., Mana, S., Mårtensson, S., Richthoff, J., Sundqvist, P., Kjölhede, H., Ola Bratt & Fredrik Liedberg, 2019, In : Scandinavian Journal of Urology.

    Research output: Contribution to journalArticle

  3. 2018
  4. The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: A validation study

    Gnanapragasam, V. J., O. Bratt, Muir, K., Lee, L. S., Huang, H. H., Stattin, P. & Lophatananon, A., 2018 Feb 28, In : BMC Medicine. 16, 1, 31.

    Research output: Contribution to journalArticle

  5. Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study

    Robinson, D., Garmo, H., Lissbrant, I. F., Widmark, A., Pettersson, A., Gunnlaugsson, A., Adolfsson, J., Ola Bratt, Per Nilsson & Stattin, P., 2018, In : European Urology. 73, 4, p. 502-511

    Research output: Contribution to journalArticle

  6. 2017
  7. Everyday life after a radical prostatectomy – A qualitative study of men under 65 years of age

    Wennick, A., Jönsson, A. K., Ola Bratt & Stenzelius, K., 2017 Oct 1, In : European Journal of Oncology Nursing. 30, p. 107-112 6 p.

    Research output: Contribution to journalArticle

  8. Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

    Loeb, S., Folkvaljon, Y., Curnyn, C., Robinson, D., Ola Bratt & Stattin, P., 2017 Oct 1, In : JAMA oncology. 3, 10, p. 1393-1398 6 p.

    Research output: Contribution to journalArticle

  9. Aiming for a holistic integrated service for men diagnosed with prostate cancer – Definitions of standards and skill sets for nurses and allied healthcare professionals

    Lamb, A. D., Thompson, S., Kinsella, N., Gerbitz, I., Chapman, E., Putt, L., Bennett, S., Thankappannair, V., Geoghegan, L., Wright, N., Stirton-Croft, A., Nixon, P., Styling, A., Whitney, D., Hodgson, L., Punt, L., Longmore, J., Carter, M., Petch, B., Rimmer, Y. & 8 othersRussell, S., Hughes-Davies, L., Mazhar, D., Shah, N. C., Gananapragasam, V. J., Doble, A., Ola Bratt & Kastner, C., 2017 Aug 1, In : European Journal of Oncology Nursing. 29, p. 31-38 8 p.

    Research output: Contribution to journalArticle

  10. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study

    Stattin, P., Sandin, F., Thomsen, F. B., Garmo, H., Robinson, D., Lissbrant, I. F., Jonsson, H. & Ola Bratt, 2017 Jul, In : European Urology. 72, 1, p. 125-134

    Research output: Contribution to journalArticle

  11. The drama of prostate cancer diagnostics

    Ola Bratt, Hugosson, J., Klotz, L. & Gnanapragasam, V., 2017 Mar 1, In : The Lancet Oncology. 18, 3, p. e132

    Research output: Contribution to journalLetter

  12. Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study

    Thorstenson, A., Garmo, H., Adolfsson, J. & Ola Bratt, 2017 Jan 1, In : Journal of Urology. 197, 1, p. 61-66 6 p.

    Research output: Contribution to journalArticle

  13. Prostatacancercentrum - navet i framtidens prostatacancersjukvård

    Ola Bratt, Göran Ahlgren, Börjedahl, A. C., Lissbrant, I. F. & Waller, C., 2017, In : Lakartidningen. 114, 5

    Research output: Contribution to journalArticle

  14. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer

    Van Hemelrijck, M., Garmo, H., Lindhagen, L., Ola Bratt, Stattin, P. & Adolfsson, J., 2017, In : European Urology. 72, 4, p. 534-541

    Research output: Contribution to journalArticle

  15. 2016
  16. Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study

    Ola Bratt, Drevin, L., Akre, O., Garmo, H. & Stattin, P., 2016 Oct 1, In : Journal of the National Cancer Institute. 108, 10, djw110.

    Research output: Contribution to journalArticle

  17. Immediate versus delayed prostatectomy: Nationwide population-based study

    Loeb, S., Folkvaljon, Y., Robinson, D., Makarov, D. V., Ola Bratt, Garmo, H. & Stattin, P., 2016 Jul 3, In : Scandinavian Journal of Urology. 50, 4, p. 246-254

    Research output: Contribution to journalArticle

  18. Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort

    Anders Bjartell, Bottai, M., Persson, J., Ola Bratt, Damber, J. E., Stattin, P. & Akre, O., 2016 Jul 3, In : Scandinavian Journal of Urology. 50, 4, p. 255-259

    Research output: Contribution to journalArticle

  19. Re: Risk of malignant melanoma in men with prostate cancer. Nationwide, population-based cohort study

    Ola Bratt, 2016 Jun 1, In : European Urology. 69, 6, p. 1158-1159 2 p.

    Research output: Contribution to journalLetter

  20. 30 procents risk få prostatacancer om en bror har diagnosen

    Ola Bratt, 2016, In : Läkartidningen. 113, 31-33

    Research output: Contribution to journalArticle

  21. A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies.

    Nordström, T., Ola Bratt, Örtegren, J., Aly, M., Adolfsson, J. & Grönberg, H., 2016, In : Scandinavian Journal of Urology. 50, 2, p. 104-109

    Research output: Contribution to journalArticle

  22. Dashboard report on performance on select quality indicators to cancer care providers

    Stattin, P., Sandin, F., Sandback, T., Damber, J-E., Lissbrant, I. F., Robinson, D., Ola Bratt & Lambe, M., 2016, In : Scandinavian Journal of Urology. 50, 1, p. 21-28

    Research output: Contribution to journalArticle

  23. The Accuracy of Prostate Biopsies for Predicting Gleason Score in Radical Prostatectomy Specimens. Nationwide trends 2000-2012.

    Danneman, D., Drevin, L., Delahunt, B., Samaratunga, H., Robinson, D., Ola Bratt, Loeb, S., Stattin, P. & Egevad, L., 2016, In : BJU International.

    Research output: Contribution to journalArticle

  24. 2015
  25. (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.

    Kjölhede, H., Göran Ahlgren, Almquist, H., Fredrik Liedberg, Lyttkens, K., Ohlsson, T. & Ola Bratt, 2015, In : World Journal of Urology. 33, 11, p. 1749-1752

    Research output: Contribution to journalArticle

  26. Clinical Management of Prostate Cancer in Men with BRCA Mutations.

    Ola Bratt & Niklas Loman, 2015, In : European Urology. 68, 2, p. 194-195

    Research output: Contribution to journalDebate/Note/Editorial

  27. Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer.

    Loeb, S., Folkvaljon, Y., Makarov, D. V., Ola Bratt, Bill-Axelson, A. & Stattin, P., 2015, In : European Urology. 67, 2, p. 233-238

    Research output: Contribution to journalArticle

  28. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer

    Ternov, K. K., Krag Jakobsen, A., Ola Bratt & Göran Ahlgren, 2015, In : Scandinavian Journal of Urology. 49, 2, p. 115-119

    Research output: Contribution to journalArticle

  29. Serum markers in prostate cancer detection.

    Ola Bratt & Hans Lilja, 2015, In : Current Opinion in Urology. 25, 1, p. 59-64

    Research output: Contribution to journalArticle

  30. Simplified intraoperative sentinel-node detection performed by the urologist accurately determines lymph-node stage in prostate cancer.

    Kjölhede, H., Ola Bratt, Gudjonsson, S., Sundqvist, P. & Fredrik Liedberg, 2015, In : Scandinavian Journal of Urology. 49, 2, p. 97-102

    Research output: Contribution to journalArticle

  31. The risk of distant metastases and cancer-specific survival in men with serum prostate-specific antigen values above 100 ng/ml.

    Stattin, K., Sandin, F., Ola Bratt & Lambe, M., 2015, In : Journal of Urology. 194, 6, p. 1594-1600

    Research output: Contribution to journalArticle

  32. Towards "next-generation" prostate cancer screening.

    Lamb, A. D. & Ola Bratt, 2015, In : The Lancet Oncology. 16, 16, p. 1579-1580

    Research output: Contribution to journalDebate/Note/Editorial

  33. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.

    Ola Bratt, Folkvaljon, Y., Hjälm Eriksson, M., Akre, O., Carlsson, S., Drevin, L., Franck Lissbrant, I., Makarov, D., Loeb, S. & Stattin, P., 2015, In : European Urology. 68, 1, p. 53-58

    Research output: Contribution to journalArticle

  34. Upper Limit of Cancer Extent on Biopsy Defining Very Low Risk Prostate Cancer.

    Ola Bratt, Folkvaljon, Y., Loeb, S., Klotz, L., Egevad, L. & Stattin, P., 2015, In : BJU International. 116, 2, p. 213-219

    Research output: Contribution to journalArticle

  35. 2014
  36. (18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.

    Kjölhede, H., Göran Ahlgren, Almquist, H., Fredrik Liedberg, Lyttkens, K., Ohlsson, T. G. & Ola Bratt, 2014, In : World Journal of Urology. 32, 4, p. 965-970

    Research output: Contribution to journalArticle

  37. The Clinical Impact of Genetic Susceptibility to Prostate Cancer.

    Ola Bratt, 2014, In : European Urology. 66, 3, p. 500-501

    Research output: Contribution to journalDebate/Note/Editorial

  38. 2013
  39. The Study of Active Monitoring in Sweden (SAMS): A randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer.

    Ola Bratt, Carlsson, S., Holmberg, E., Holmberg, L., Johansson, E., Josefsson, A., Nilsson, A., Nyberg, M., Robinsson, D., Sandberg, J., Sandblom, D. & Stattin, P., 2013, In : Scandinavian Journal of Urology. 47, 5, p. 347-355

    Research output: Contribution to journalReview article

  40. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL.

    Ladjevardi, S., Berglund, A., Varenhorst, E., Ola Bratt, Widmark, A. & Sandblom, G., 2013, In : BJU International. 111, 3, p. 381-388

    Research output: Contribution to journalArticle

  41. 2012
  42. Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.

    Kjölhede, H., Göran Ahlgren, Almquist, H., Fredrik Liedberg, Lyttkens, K., Ohlsson, T. G. & Ola Bratt, 2012, In : BJU International. 110, 10, p. 1501-1506

    Research output: Contribution to journalArticle

  43. Concordance of Tumor Differentiation Among Brothers with Prostate Cancer

    Jansson, K. F., Akre, O., Garmo, H., Bill-Axelson, A., Adolfsson, J., Stattin, P. & Ola Bratt, 2012, In : European Urology. 62, 4, p. 656-661

    Research output: Contribution to journalArticle

  44. Current routines for transrectal ultrasound-guided prostate biopsy: A web-based survey by the Swedish Urology Network

    Carlsson, S., Ola Bratt, Stattin, P. & Egevad, L., 2012, In : Scandinavian Journal of Urology and Nephrology. 46, 6, p. 405-410

    Research output: Contribution to journalArticle

  45. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer

    Berglund, A., Garmo, H., Robinson, D., Tishelman, C., Holmberg, L., Ola Bratt, Adolfsson, J., Stattin, P. & Lambe, M., 2012, In : European Journal of Cancer. 48, 1, p. 75-84

    Research output: Contribution to journalArticle

  46. Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden

    Thorstenson, A., Ola Bratt, Akre, O., Hellborg, H., Holmberg, L., Lambe, M., Bill-Axelson, A., Stattin, P. & Adolfsson, J., 2012, In : European Journal of Cancer. 48, 11, p. 1672-1681

    Research output: Contribution to journalArticle

  47. 2011
  48. Mortality Among Men with Locally Advanced Prostate Cancer Managed with Noncurative Intent: A Nationwide Study in PCBaSe Sweden

    Akre, O., Garmo, H., Adolfsson, J., Lambe, M., Ola Bratt & Stattin, P., 2011, In : European Urology. 60, 3, p. 554-563

    Research output: Contribution to journalArticle

  49. MORTALITY AMONG MEN WITH LOCALLY ADVANCED PROSTATE CANCER MANAGED WITH NON-CURATIVE INTENT; A NATIONWIDE STUDY IN PCBASE SWEDEN

    Akre, O., Garmo, H., Adolfsson, J., Lambe, M., Ola Bratt & Stattin, P., 2011, In : European Urology Supplements. 10, 2, p. 239-240

    Research output: Contribution to journalPublished meeting abstract

  50. Psychiatric treatment in men with prostate cancer - Results from a Nation-wide, population-based cohort study from PCBaSe Sweden

    Bill-Axelson, A., Garmo, H., Nyberg, U., Lambe, M., Ola Bratt, Stattin, P., Adolfsson, J. & Steineck, G., 2011, In : European Journal of Cancer. 47, 14, p. 2195-2201

    Research output: Contribution to journalArticle

  51. READMISSION AFTER RADICAL PROSTATECTOMY. NATION-WIDE, POPULATION-BASED STUDY IN PCBASE SWEDEN

    Fridriksson, J., Holmberg, E., Ola Bratt, Garmo, H., Adolfsson, J., Lambe, M., Bill-Axelson, A. & Stattin, P., 2011, In : European Urology Supplements. 10, 2, p. 279-279

    Research output: Contribution to journalPublished meeting abstract

  52. 2010
  53. Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden.

    Van Hemelrijck, M., Garmo, H., Holmberg, L., Ingelsson, E., Ola Bratt, Bill-Axelson, A., Lambe, M., Stattin, P. & Adolfsson, J., 2010, In : Journal of Clinical Oncology. Jul 1, p. 3448-3456

    Research output: Contribution to journalArticle

  54. Effects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates.

    Ola Bratt, Garmo, H., Adolfsson, J., Bill-Axelson, A., Holmberg, L., Lambe, M. & Stattin, P., 2010, In : Journal of the National Cancer Institute. 102, p. 1336-1343

    Research output: Contribution to journalArticle

Previous 1 2 Next